- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04634773
Unravelling the Etiology of Shoulder Osteoarthritis (UESOA)
Osteoarthritis (OA) is a progressive disease resulting from the degradation of synovial joint articular cartilage over time.
The hallmark symptom is diffuse aching and progressive pain made worse with activity. Loss of range of motion and compromised function inevitably follow. This degenerative disease can affect the shoulder joint. When symptoms become refractory to conservative treatment such as anti-inflammatory medication, steroid injections, activity modification or physical therapy; surgery (total or reverse shoulder arthroplasty) may be considered.
Idiopathic shoulder OA is typically characterized by posterior subluxation of the humeral head upon the glenoid and posterior bone loss. An imbalance in the application of forces applied to the proximal humerus by the posterior and anterior rotator cuff muscles has been postulated to be the leading cause of idiopathic shoulder OA. However, there is only preliminary evidence to support this theory and the etiology of this pattern of deformity is unknown. The theory the posterior humeral head subluxation is a precursor to OA is only supported by very low-level evidence and no longitudinal studies have been conducted. As a result, the cause and natural history of shoulder OA remains unknown.
Research into this area is urgently needed to generate knowledge that will inform future treatments aimed at modifying and slowing the progression of shoulder OA and to reduce the need for shoulder replacement therapy.
The aim of this project is to develop an understanding of the pathophysiology of shoulder OA.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Purpose: The aim of this project is to develop an understanding of the pathophysiology of shoulder OA. This project will recruit two groups of 30 participants, (60 participants in total) and follow them over a period of 5-years.
Group 1- Participants with posterior subluxation of the humeral head and show early signs of degeneration in their shoulder 'disease group' Group 2- Participants with posterior subluxation of the humeral head and show no signs of degeneration 'control/healthy' group
Hypotheses: The investigators hypothesize that there are several factors that contribute to the development of shoulder OA. Uncovering those pathways will lead to more targeted therapy. (1) The posterior rotator cuff muscles (infraspinatus/teres minor) apply relatively greater force than the anterior (subscapularis) cuff; an imbalance in the force couple occurs and the humeral head translates posteriorly on the glenoid; progressive posterior subluxation of the humeral head occurs and degeneration of the glenoid and humeral head cartilage follow. (2) Posterior subluxation of the humeral head is associated with progressive cartilage proteoglycan loss. (3) Pre-morbid glenoid morphology including increased retroversion is associated with the development of shoulder OA.
Participant Involvement: The following will be completed with participants: T1Rho Magnetic Resonance Imaging (MRI), quantitative Computed Tomography (qCT), functional and motion analysis at baseline, year 2 and year 4 in the 'affected' shoulder in both groups 1 and 2. These tests will also be conducted on the asymptomatic, contralateral shoulder in Group 1 participants at baseline and year 4. The finite element model validation will be performed in years 2 and 3, and participant-specific finite element analysis (which has no active participant involvement) will occur in years 3 to 5. Overall study analysis will occur in year 5. This project will be done in two-parts. The first part will consist of six participants; assuming further funding is obtained, part two of the study will proceed. The second part of the project will be based on successfully obtaining funds to continue the remainder of the study recruitment (54 participants) and testing. As pilot data is urgently needed to secure granting funds to support this overall project, the investigators will commence with recruiting the first 6 participants. Once further funds are secured, the remaining portion (recruitment of 54 participants) of the project will continue.
Objectives: (1) Determine whether patients with posterior humeral head subluxation have an imbalance between the posterior and anterior rotator cuff muscles. Objective 1 will be assessed through T1Rho MRI, and functional testing/motion analysis.
(2) Determine whether patients with static posterior subluxation of the humeral head are at risk of degenerative changes (i.e. proteoglycan loss). Objective 2 will be assessed through T1Rho MRI and qCT scans.
(3) Determine which joint factors are associated with progression of OA. This will be assessed using qCT scans and finite element model analysis.
Clinical Relevance: The cause is shoulder OA is unknown, and the burden and costs associated with this degenerative disease are increasing with our aging population. Research in this area is urgently needed to generate knowledge which will inform future treatments which may modify and slow the progression of shoulder OA, and to reduce the need for shoulder replacement therapy.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Ottawa, Ontario, Canada, K1N 6N5
- University of Ottawa
-
Ottawa, Ontario, Canada, K1S5B6
- Carleton University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults <60 years of age
- Posterior humeral head subluxation >55% (determined from imaging)
Exclusion Criteria:
- >60 years of age
- History of shoulder instability
- History of shoulder trauma including fracture
- Neurological disorders of the upper limb
- Imaging evidence of humeral head or glenoid bony deformity
- Rotator cuff pathology
- Labral pathology
- Pre-existing joint deformity (OA) cases greater than grade I (as per Samilson and Prieto)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1: Early Degeneration ('Disease')
Those who have posterior subluxation of the humeral head and show early signs of degeneration in their shoulder.
|
A low-dose, or quantitative (q) CT scan will be performed on the shoulder. This CT scan will be done to assess the bony structure of the shoulder, as well as bone strength, which can influence the health of the cartilage. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. A T1Rho MRI will be performed on the shoulder. This imaging technique uses a special sequence and will be used to assess the muscles and tendons around the shoulder. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. |
Active Comparator: Group 2: No Degeneration ('Healthy')
Those who have posterior subluxation of the humeral head and show no signs of degeneration.
|
A low-dose, or quantitative (q) CT scan will be performed on the shoulder. This CT scan will be done to assess the bony structure of the shoulder, as well as bone strength, which can influence the health of the cartilage. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. A T1Rho MRI will be performed on the shoulder. This imaging technique uses a special sequence and will be used to assess the muscles and tendons around the shoulder. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. Motion analysis is the study of how joints move and which muscles fire during specific movements. In the lab, participants will be asked to perform movements that they might do during a typical day or when exercising. Group 1 participants will complete this scan at baseline, 2-years and 4-years in the affected shoulder, and at baseline and 4-years in the opposite, unaffected shoulder. Group 2 participants will complete this scan at baseline, 2-years and 4-years. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
T1Rho MRI
Time Frame: 5-Years Post-Allocation
|
MRI will be used to measure the muscle-fat ratio, and tendon thickness.
Increased fat-infiltration, and tendon thinning indicates a worse outcome.
|
5-Years Post-Allocation
|
qCT (Low Dose CT)
Time Frame: 5-Years Post-Allocation
|
Used to measure bone loss and density.
Increased bone loss, and decreased density indicate a worse outcome.
|
5-Years Post-Allocation
|
Motion Analysis
Time Frame: 5-Years Post-Allocation
|
A kinematic evaluation of the shoulder while performing functional tasks will help us determine how the rotator cuff muscle imbalance influences the shoulder joint kinematics.
|
5-Years Post-Allocation
|
Finite Element Analysis
Time Frame: 5-Years Post-Allocation
|
This will be combined with motion analysis results to gain a better understanding of the internal loading within the tissues of the joint that could explain degenerative changes observed by imaging.
Increased stresses, and muscle imbalance result in a worse outcome.
|
5-Years Post-Allocation
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Peter Lapner, MD, FRCSC, The Ottawa Hospital Research Institute
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20200766-01H
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis of the Shoulder
-
Pacira Pharmaceuticals, IncCompletedOsteoarthritis of the Hip | Osteoarthritis of the ShoulderUnited States
-
MaterialiseEnrolling by invitationOsteoarthritis of the Shoulder | Arthroplasty, Replacement, Shoulder | Glenoid CavityBelgium, Netherlands
-
University of RzeszowCompleted
-
OrthoCarolina Research Institute, Inc.CompletedOsteoarthritis of the ShoulderUnited States
-
Danderyd HospitalKarolinska Institutet; Ascension Orthopedics, Inc.; Swedish Shoulder and Elbow...UnknownOsteoarthritis of the ShoulderSweden
-
Ottawa Hospital Research InstituteRecruiting
-
Hannover Medical SchoolRecruitingOsteoarthritis of the ShoulderGermany
-
Joint Preservation Centre of BCCompletedOsteoarthritis of the ShoulderCanada
-
University of Alabama at BirminghamWithdrawnAdhesive Capsulitis | Osteoarthritis of the ShoulderUnited States
-
Herlev and Gentofte HospitalZealand University Hospital; DePuy SynthesUnknownProximal Humeral Fracture | Osteoarthritis of the ShoulderDenmark
Clinical Trials on Low-dose CT
-
Kyoung Ho Lee, MDSeoul National University Bundang Hospital; Ministry of Health & Welfare, Korea and other collaboratorsCompleted
-
Seoul National University Bundang HospitalGE Healthcare; National Research Foundation of KoreaCompletedAppendicitisKorea, Republic of
-
Yale UniversityAgency for Healthcare Research and Quality (AHRQ)Completed
-
Sang-Won UmNot yet recruitingHealth Risk Behaviors
-
University Hospital, GenevaCompleted
-
Oncology Teaching Hospital, BaghdadEnrolling by invitation
-
Hospices Civils de LyonCompletedTelangiectasia, Hereditary Hemorrhagic | Rendu Osler DiseaseFrance
-
The University of QueenslandActive, not recruitingNeoplasms | Respiratory Tract Diseases | Lung Diseases | Neoplasms by Site | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Non-small Cell Lung Cancer | Smokers at Risk of Lung CancerAustralia, Canada
-
Oslo University HospitalOdense University HospitalCompletedAbdominal Pain | Acute Pain | Acute Pancreatitis | Acute Cholecystitis | Acute AppendicitisNorway, Denmark
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted